Skip to main content
. 2020 Aug 25;10(23):10606–10618. doi: 10.7150/thno.45311

Table 1.

Clinicopathological features of 14 patients with double SCCs.

Patient ID Gender Age Synchronous/metachronous Tumor ID Tumor location Interval time (months) Follow-up (months) Pathological diagnosis Molecular diagnosis
P1 Male 43 Metachronous T Esophagus 26 Deceased (10) Metastasis Metastasis
LN LN
D Lung
P2 Male 49 Synchronous T Esophagus 0 Deceased (3) Metastasis Metastasis
LN LN
D Lung
P3 Male 73 Synchronous T Esophagus 0 Deceased (35) Metastasis Primary
LN LN
D Lung
P4 Male 42 Metachronous T Esophagus 12 Alive (90) Metastasis Primary
LN LN
D Lung
P5 Male 54 Synchronous T Esophagus 4 Deceased (26) Metastasis Metastasis
D Kidney
P6 Male 67 Synchronous T Esophagus 0 Deceased (23) Metastasis Metastasis
LN LN
D Lung
P7 Male 55 Synchronous T Esophagus 0 Deceased (25) Metastasis Metastasis
D Lung
P8 Male 50 Synchronous T Esophagus 5 Alive (3) Metastasis Metastasis
LN LN
D Brain
P9 Male 56 Metachronous T Esophagus 18 Alive (53) Metastasis Metastasis
LN LN
D Lung
P10 Male 58 Synchronous T Esophagus 0 Alive (13) Metastasis Primary
LN LN
D Lung
P11 Male 80 Synchronous T Esophagus 0 Alive (3) Metastasis Metastasis
LN LN
D Lung
P12 Male 62 Synchronous T Esophagus 0 Alive (12) Metastasis Primary
LN LN
D Lung
P13 Male 49 Metachronous T Esophagus 36 Alive (41) Metastasis Metastasis
LN LN
D Lung
P14 Male 61 Synchronous T Esophagus 0 Deceased (20) Metastasis Primary
LN LN
D Lung